Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in brooklyn, New York

Clinical Infectious Diseases

Volumn 48, Issue 7, 2009, Pages 894-901

  Weiss, Don ^a,f   Stern, Eric J ^c,d   Zimmerman, Christopher ^a   Bregman, Brooke ^a   Yeung, Alice ^a   Das, Debjani ^a   Dentinger, Catherine M ^a,c   Marx, Melissa A ^a   Kornblum, John ^a   Lee, Lillian ^a   Halse, Tanya A ^b   Mayer, Leonard W ^d   Hatcher, Cynthia P ^d   Theodore, M Jordan ^d   Schmink, Susanna ^d   Harcourt, Brian H ^d   Zucker, Jane R ^a,e   Layton, Marci ^a   Clark, Thomas A ^d  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^b WADSWORTH CENTER   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Meningitis and Vaccine Preventable Diseases Branch   (United States)

^e NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^f NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE; METHADONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COCAINE DEPENDENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE TRANSMISSION; EPIDEMIC; FEMALE; HEROIN DEPENDENCE; HUMAN; INFECTION RISK; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MENINGOCOCCOSIS; MOLECULAR EPIDEMIOLOGY; MORTALITY; OPIATE ADDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SCHOOL CHILD; SOCIAL WELFARE; UNITED STATES; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL TYPING TECHNIQUES; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; DNA FINGERPRINTING; DRUG USERS; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; HUMANS; INFANT; MALE; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; MIDDLE AGED; NEISSERIA MENINGITIDIS, SEROGROUP C; NEW YORK CITY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 63649092191     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/597257     Document Type: Article

References (29)

1. 1.Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N Engl J Med 2001;344:1378-88.
2. Brooks R, Woods CW, Benjamin DK, Rosenstein NE. Increased case- fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002. Clin Infect Dis 2006;43:49-54.
3. Rosenstein NE, Perkins BA, Stephens DS, et al. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis 1999;180:1894-901.
4. Bilukha OO, Rosenstein N; National Center for Infectious Diseases, Centers for Disease Control and Prevention. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005;54:1-21.
5. Moura AS, Pablos-Mendez, A, Layton M, Weiss D. Epidemiology of meningococcal disease, New York City, 1989-2000. Emerg Infect Dis 2003;9:355-61.
6. Centers for Disease Control and Prevention. Serogroup W-135 meningococcal disease among travelers returning from Saudi Arabia - United States, 2000. MMWR Morb Mortal Wkly Rep 2000;49:345-6.
7. Popovic T, Schmink S, Rosenstein NA, et al. Evaluation of'pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup C. J Clin Microbiol 2001;39:75-85.
8. Multi Locus Sequence Typing Web site. Available at: http://pubmlst. org/neisseria. Accessed 30 January 2009.
9. Maiden MCJ, Bygraves JA, Feil E, et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 1998; 95: 3140-5.
10. Kellerman SE, McCombs K, Ray M, et al. Genotype-specific carriage of Neisseria meningitides in Georgia counties with hyper- and hypo- sporadic rates of meningococcal disease. J Infect Dis 2002; 186:40 - 8.
11. Krause G, Blackmore G, Wiersma S, et al. Marijuana use and social networks in a community outbreak of meningococcal disease. South Med J 2001;94:482-4.
12. Finn R, Groves C, Coe M, Pass M, Harrison LH. Cluster of serogroup C meningococcal disease associated with attendance at a party. South Med I 2001;94:1192-4.
13. Harrison LH, Kreiner CJ, Shutt KA, et al. Risk factors for meningococcal disease in students in grades 9 - 12. Ped Infect Dis Journal 2008;27:193-9.
14. Imrey PB, Jackson LA, Ludwinski PH, et al. Outbreak of serogroup C meningococcal disease associated with campus bar patronage. Am J Epidemiol 1996; 143:624-30.
15. Coen PG, Tully J, Stuart JM, Ashby D, Viner DA, Booy R. Is it exposure to cigarette smoke or to smokers which increases the risk of meningococcal disease in teenagers? Int J Epidemiol 2006;35:330-6.
16. Orr HI, Gray SI, Macdonald M, Stuart JM. Saliva and meningococcal transmission. Emerging Infect Dis 2003;9:1314-5.
17. Perper JA, Van Thiel DH. Respiratory complications of cocaine use. Recent Dev Alcohol 1992;10:363-77.
18. De Waal EJ, Van Der Laan, Van Loveren H. Effects of prolonged exposure to morphine and methadone on in vivo parameters of immune function in rats. Toxicology 1998;129:201-10.
19. LeVier DG, Brown RD, Musgrove DL, et al. The effect of methadone on the immune status of B6C3F1 mice. Fundam Appl Toxicol 1995; 24:275-84.
20. Diaz S, Specter S, Coffey RG. Suppression of lymphocyte adenosine 3':5'-cyclic monophosphate (cAMP) by delta-9-tetrahydrocannabinol. Int J Immunopharmacol 1993;15:523-32.
21. Conyn-van Spaendonck MA, Reintjes R, Spanjaard L, van Kregten E, Kraaijeveld AG, Jacobs PH. Meningococcal carriage in relation to an outbreak of invasive disease due to Neisseria meningitidis serogroup C in the Netherlands. J Infect 1999; 39:42-8.
22. Patrick DM, Champagne S, Goh SH, et al. Neisseria meningitidis carriage during an outbreak of serogroup C disease. Clin Infect Dis 2003;37:1183-8.
23. Harrison LH. Prospects for vaccine prevention of meningococcal infection. Clin Micro Rev 2006; 19:142-64.
24. Siamak P, Yazdankhah, Caugant DA. Neisseria meningitidis and overview of the carriage state. J Med Microbiol 2004;53:821-32.
25. Trotter CL. The natural history of meningococcal carriage. Epidemiol Infect 2006;134:556-66.
26. Ala'aldeen DA, Neal KR, Ait-Tahar K, et al. Dynamics of meningococcal long-term carriage among university students and their implications for mass vaccination. J Clin Microbiol 2000;38:2311-6.
27. Trotter CL, Andrews NJ, Kaczmarski EB, Miller E, Ramsey ME. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 2004; 364:365-7.
28. De Wals P, Deceuninck G, Boulianne N, De Series G. Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine. LAMA 2004; 292:249 1-4.
29. Larrauri A, Cano R, Garcia M, Mateo S. Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain. Vaccine 2005;23:4097-100.